Small-fibre polyneuropathy caused by chemical agent resistant coating.
Marshall B, Sharma Md U, Tsakadze Md N, Rossi Md FH.
BMJ Case Rep. 2021 Jun 1;14(6):e242438. doi: 10.1136/bcr-2021-242438.
Non-pharmacological Interventions on Pain and Quality of Life in Chemotherapy Induced Polyneuropathy: Systematic Review and Meta-Analysis.
Papadopoulou M, Stamou M, Bakalidou D, Moschovos C, Zouvelou V, Zis P, Tzartos J, Chroni E, Michopoulos I, Tsivgoulis G.
In Vivo. 2023 Jan-Feb;37(1):47-56. doi: 10.21873/invivo.13053.
Fluoroquinolone-Induced Demyelinating Polyneuropathy.
Al-Chalabi M, Martinez Salazar A, Bradshaw A.
J Clin Neuromuscul Dis. 2024 Sep 1;26(1):49-53. doi: 10.1097/CND.0000000000000496.
Atorvastatin-induced polyneuropathy.
Jacobs MB.
Ann Intern Med. 2004 Jul 6;141(1):77. doi: 10.7326/0003-4819-141-1-200407060-00024.
Organophosphate-induced delayed polyneuropathy.
Lotti M, Moretto A.
Toxicol Rev. 2005;24(1):37-49. doi: 10.2165/00139709-200524010-00003.
[Nitrous oxide-induced polyneuropathy].
Conjaerts SHP, Bruijnes JE, Beerhorst K, Beekman R.
Ned Tijdschr Geneeskd. 2017;161:D2044.
Atorvastatin-induced polyneuropathy.
Silverberg C.
Ann Intern Med. 2003 Nov 4;139(9):792-3. doi: 10.7326/0003-4819-139-9-200311040-00022.
Toxic Neuropathies.
Karam C, Dyck PJ.
Semin Neurol. 2015 Aug;35(4):448-57. doi: 10.1055/s-0035-1558977. Epub 2015 Oct 6.
Axonal sensorimotor polyneuropathy after starting guselkumab.
Hamadah I, Chisti MA.
J Dermatolog Treat. 2022 Jun;33(4):2371-2372. doi: 10.1080/09546634.2021.1914304. Epub 2021 Aug 1.
[Taxane-induced polyneuropathy - current possibilities of prediction and management].
Jablonická M, Žideková L, Mladosievičová B.
Vnitr Lek. 2021 Winter;67(1):26-31.
